OncXerna Therapeutics is Drug Discovery in United States that focus on biomarker platform business. Founded in 2018. They cover business area such as developer, cancer therapy, cancer patient, precision, RNA-base biomarker platform, immune-modulatory monoclonal antibody, immune checkpoint inhibitor, healthcare provider, effective therapy.
2018
( 6 years old in 2024 )
Biomarker Platform
-
300 Fifth Avenue
Suite 6040
Waltham, MA 02451
United States
Private
developercancer therapycancer patientprecisionRNA-base biomarker platformimmune-modulatory monoclonal antibodyimmune checkpoint inhibitorhealthcare providereffective therapy
* We use standard office opening hours in near OncXerna Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
OncXerna Therapeutics is Drug Discovery business from United States that founded in 2018 (6 years old in 2024), OncXerna Therapeutics business is focusing on Biomarker Platform.
OncXerna Therapeutics headquarter office and corporate office address is located in 300 Fifth Avenue Suite 6040 Waltham, MA 02451 United States.
OncXerna Therapeutics was founded in United States.
In 2024, OncXerna Therapeutics is currently focus on biomarker platform sector.
Above is snippet of Google Trends for "biomarker platform" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with OncXerna Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
